Acadian Asset Management LLC Adc Therapeutics Sa Transaction History

Acadian Asset Management LLC

  • $32.2 Billion
  • Q3 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 06, 2024
BUY
$2.55 - $5.09 $41,957 - $83,750
16,454 New
16,454 $51,000
Q4 2023

Feb 13, 2024
SELL
$0.47 - $1.79 $5,259 - $20,030
-11,190 Reduced 7.17%
144,858 $240,000
Q3 2023

Nov 13, 2023
BUY
$0.72 - $2.37 $96,613 - $318,020
134,186 Added 613.79%
156,048 $138,000
Q2 2023

Aug 07, 2023
BUY
$1.9 - $2.66 $41,537 - $58,152
21,862 New
21,862 $45,000
Q4 2022

Feb 14, 2023
BUY
$2.87 - $5.24 $7,734 - $14,121
2,695 New
2,695 $10,000

Others Institutions Holding ADCT

# of Institutions
79
Shares Held
55M
Call Options Held
82.7K
Put Options Held
31.5K
View Full List

About ADC Therapeutics SA

ADCT Quotes by TradingView
  • Ticker ADCT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 77,645,296
  • Market Cap $206M
  • Description
  • ADC Therapeutics SA, a commercial-stage biotechnology company, develops antibody drug conjugates (ADC) for patients suffering from hematological malignancies and solid tumors. Its flagship product ZYNLONTA that is in Phase II clinical trial for the treatment of relapsed or refractory diffuse large B-cell lymphoma (DLBCL) and follicular lymphoma;...
More about ADCT
Track This Portfolio

Track Acadian Asset Management LLC Portfolio

Follow Acadian Asset Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Acadian Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Acadian Asset Management LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email